Home ›
Trademark Categories ›
Pharmaceuticals ›
2001 ›
TH ›
THROMBOVIEW
Trademark search for:
THROMBOVIEW
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2014-04-28 — Application filed
2014-08-28 — Sn assigned for sect 66a subseq desig from ib
2014-08-29 — Application filed
2014-09-02 — Application filed
2014-09-02 — Assigned to examiner
2014-09-05 — Final disposition recorded
2014-09-06 — Application filed
2014-09-06 — Office action issued
2014-09-09 — Office action issued
2014-09-09 — Office action issued
2014-10-02 — Correction transaction received from ib
2014-10-03 — Correction from ib entered - attorney review required
2014-10-06 — Attorney review completed
2014-10-10 — Office action issued
2015-03-05 — Teas revoke/app/change addr of atty/dom rep received
2015-03-05 — Attorney/dom.rep.revoked and/or appointed
2015-03-05 — Office action issued
2015-03-12 — Teas/email correspondence entered
2015-03-12 — Assigned to lie
2015-03-12 — Correspondence received in law office
2015-03-25 — Suspension letter written
2015-03-25 — Letter of suspension e-mailed
2015-03-25 — Notification of letter of suspension e-mailed
2015-10-06 — Report completed suspension check case still suspended
2016-03-02 — Notification of possible opposition created, to be sent to ib
2016-03-02 — Notification of possible opposition sent to ib
2016-03-18 — Notification of possible opposition - processed by ib
2016-04-07 — Suspension checked - to attorney for action
2016-04-26 — Approved for pub - principal register
2016-05-03 — Law office publication review completed
2016-05-18 — Notification of notice of publication e-mailed
2016-05-18 — Notice of start of opposition period created, to be sent to ib
2016-05-18 — Notification of possible opposition sent to ib
2016-06-07 — Published for opposition
2016-06-07 — Official gazette publication confirmation e-mailed
2016-07-01 — Notification of possible opposition - processed by ib
2016-08-23 — Registered-principal register
2016-11-23 — Final disposition recorded
2017-01-27 — Generic madrid transaction sent to ib
2017-01-27 — Generic madrid transaction created
2017-05-20 — Final disposition recorded
2021-08-23 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2023-03-03 — Cancelled section 71
2023-09-21 — Final status recorded
2023-11-03 — Total invalidation of reg ext protection created
2024-04-23 — Notification of effect of cancellation of intl reg e-mailed
2024-04-23 — Death of international registration
2024-04-23 — Notification of effect of cancellation of intl reg e-mailed
2025-03-31 — Invalidation reviewed - no action required by office
Owner Information
Agen Biomedical Limited; ACN 010 528 980
AU
Agen Biomedical Limited; ACN 010 528 980
AU
Agen Biomedical Limited; ACN 010 528 980
AU
Correspondent
David A. Plumley CHRISTIE, PARKER & HALE, LLP P.O. Box 29001 Glendale, CA 91209-9001 UNITED STATES
Filing Details
Filing Date:
2014-04-28
Status Date:
2023-09-21
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.